Gump F E, Jicha D L, Ozello L
Department of Surgery, Columbia Presbyterian Medical Center, New York, N.Y.
Surgery. 1987 Nov;102(5):790-5.
The in situ concept was introduced in an effort to clarify the transition between benign epithelium and invasive cancer, and for that reason it focused on histologic changes. Lobular carcinoma in situ was first described in these terms and continues to be considered a purely microscopic lesion that never makes a mass in the breast. A very different situation exists in cases of ductal carcinoma in situ (DCIS), because both gross and microscopic disease exists together. As a result, it has been difficult to evaluate competing treatment options for the DCIS lesion. This study was undertaken to better characterize patients with DCIS lesions. Seventy consecutive patients with DCIS who underwent treatment at our institution were analyzed and two subgroups were identified. The method of presentation and the distribution of cancer in the breast as well as in the regional lymph nodes were examined. The study shows that differentiation between gross and purely microscopic DCIS is feasible and must be accomplished if treatment recommendations are to be made on a rational basis.
原位癌的概念是为了阐明良性上皮与浸润性癌之间的转变而引入的,因此它关注组织学变化。小叶原位癌最初就是按照这些术语来描述的,并且一直被认为是一种纯粹的微观病变,在乳腺中不会形成肿块。导管原位癌(DCIS)的情况则大不相同,因为大体病变和微观病变同时存在。因此,很难评估针对DCIS病变的各种治疗方案。本研究旨在更好地描述DCIS病变患者的特征。对在我们机构接受治疗的70例连续的DCIS患者进行了分析,并确定了两个亚组。研究了疾病的呈现方式以及癌症在乳腺和区域淋巴结中的分布情况。该研究表明,区分大体DCIS和纯粹微观的DCIS是可行的,并且如果要在合理的基础上做出治疗建议,就必须做到这一点。